Targeting loss of heterozygosity for cancer-specific immunotherapy.
Hwang MS, Mog BJ, Douglass J, Pearlman AH, Hsiue EH, Paul S, DiNapoli SR, Konig MF, Pardoll DM, Gabelli SB, Bettegowda C, Papadopoulos N, Vogelstein B, Zhou S, Kinzler KW.
Hwang MS, et al. Among authors: gabelli sb.
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):e2022410118. doi: 10.1073/pnas.2022410118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33731480
Free PMC article.